Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocytes

Journal of Neuroimmunology

Volumn 238, Issue 1-2, 2011, Pages 73-80

  Jyonouchi, Harumi ^a   Geng, Lee ^a   Streck, Deanna L ^a   Toruner, Gokce A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Autism spectrum disorders (ASD); CCL2; Cytokines; Peripheral blood (PB) monocytes; TLRs; Transcript profiling

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ARTICLE; AUTISM; BEHAVIOR DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM INFECTION; DYSBIOSIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MALE; MONOCYTE; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UPREGULATION;

ADOLESCENT; ADULT; BEHAVIORAL SYMPTOMS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 80052864423     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.07.001     Document Type: Article

References (50)

1. Aleksic B., Kushima I., Ito Y., Nakamura Y., Ujike H., Suzuki M., Inada T., Hashimoto R., Takeda M., Iwata N., Ozaki N. Genetic association study of KREMEN1 and DKK1 and schizophrenia in a Japanese population. Schizophr. Res. 2010, 118:113-117.
2. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Altered T cell responses in children with autism. Brain Behav. Immun. 2011, 5:840-849.
3. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J. Neuroimmunol. 2011, 232:196-199.
4. Ashwood P., Wakefield A.J. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 2006, 173:126-134.
5. Baharnoori M., Bhardwaj S.K., Srivastava L.K. Neonatal behavioral changes in rats with gestational exposure to lipopolysaccharide: a prenatal infection model for developmental neuropsychiatric disorders. Schizophr. Bull. 2010, [Epub ahead of print].
6. Bale T.L., Baram T.Z., Brown A.S., Goldstein J.M., Insel T.R., McCarthy M.M., Nemeroff C.B., Reyes T.M., Simerly R.B., Susser E.S., Nestler E.J. Early life programming and neurodevelopmental disorders. Biol. Psychiatry 2010, 68:314-319.
7. Bradford M., Law M.H., Megson I.L., Wei J. The functional significance of the TGM2 gene in schizophrenia: a correlation of SNPs and circulating IL-2 levels. J. Neuroimmunol. 2011, 232:5-7.
8. Bucan M., Abrahams B.S., Wang K., Glessner J.T., Herman E.I., Sonnenblick L.I., Alvarez Retuerto A.I., Imielinski M., Hadley D., Bradfield J.P., Kim C., Gidaya N.B., Lindquist I., Hutman T., Sigman M., Kustanovich V., Lajonchere C.M., Singleton A., Kim J., Wassink T.H., McMahon W.M., Owley T., Sweeney J.A., Coon H., Nurnberger J.I., Li M., Cantor R.M., Minshew N.J., Sutcliffe J.S., Cook E.H., Dawson G., Buxbaum J.D., Grant S.F., Schellenberg G.D., Geschwind D.H., Hakonarson H. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 2009, 5:e1000536.
9. Buie T., Campbell D.B., Fuchs G.J., Furuta G.T., Levy J., Vandewater J., Whitaker A.H., Atkins D., Bauman M.L., Beaudet A.L., Carr E.G., Gershon M.D., Hyman S.L., Jirapinyo P., Jyonouchi H., Kooros K., Kushak R., Levitt P., Levy S.E., Lewis J.D., Murray K.F., Natowicz M.R., Sabra A., Wershil B.K., Weston S.C., Zeltzer L., Winter H. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 2010, 125(Suppl. 1):S1-S18.
10. Butrus S., Portela R. Ocular allergy: diagnosis and treatment. Ophthalmol. Clin. N. Am. 2005, 18:485-492. v.
11. Cai G., Edelmann L., Goldsmith J.E., Cohen N., Nakamine A., Reichert J.G., Hoffman E.J., Zurawiecki D.M., Silverman J.M., Hollander E., Soorya L., Anagnostou E., Betancur C., Buxbaum J.D. Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. BMC Med. Genomics 2008, 1:50.
12. Cook E.H., Scherer S.W. Copy-number variations associated with neuropsychiatric conditions. Nature 2008, 455:919-923.
13. Crack P.J., Bray P.J. Toll-like receptors in the brain and their potential roles in neuropathology. Immunol. Cell Biol. 2007, 85:476-480.
14. Curatolo P., Napolioni V., Moavero R. Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. J. Child Neurol. 2010, 25:873-880.
15. Davoust N., Vuaillat C., Androdias G., Nataf S. From bone marrow to microglia: barriers and avenues. Trends Immunol. 2008, 29:227-234.
16. De Miranda J., Yaddanapudi K., Hornig M., Villar G., Serge R., Lipkin W.I. Induction of toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances. MBio 2010, 1.
17. Djukic M., Mildner A., Schmidt H., Czesnik D., Bruck W., Priller J., Nau R., Prinz M. Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 2006, 129:2394-2403.
18. El-Fishawy P., State M.W. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr. Clin. N. Am. 2010, 33:83-105.
19. Enstrom A.M., Onore C.E., Van de Water J.A., Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 2010, 24:64-71.
20. Gonzales M.L., LaSalle J.M. The role of MeCP2 in brain development and neurodevelopmental disorders. Curr. Psychiatry Rep. 2010, 12:127-134.
21. Gregg J.P., Lit L., Baron C.A., Hertz-Picciotto I., Walker W., Davis R.A., Croen L.A., Ozonoff S., Hansen R., Pessah I.N., Sharp F.R. Gene expression changes in children with autism. Genomics 2008, 91:22-29.
22. Hsiao E.Y., Patterson P.H. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav. Immun. 2011, 4:604-615.
23. Jin S.Z., Wu N., Xu Q., Zhang X., Ju G.Z., Law M.H., Wei J. A study of circulating gliadin antibodies in schizophrenia among a Chinese population. Schizophr. Bull. 2010, [Epub ahead of print].
24. Jonsson L., Ljunggren E., Bremer A., Pedersen C., Landen M., Thuresson K., Giacobini M., Melke J. Mutation screening of melatonin-related genes in patients with autism spectrum disorders. BMC Med. Genomics 2010, 3:10.
25. Jyonouchi H. Food allergy and autism spectrum disorders: is there a link?. Curr. Allergy Asthma Rep. 2009, 9:194-201.
26. Jyonouchi H. Autism spectrum disorders and allergy: observation from a pediatric allergy/immunology clinic. Expert. Rev. Clin. Immunol. 2010, 6:397-411.
27. Jyonouchi H., Geng L., Cushing-Ruby A., Monteiro I.M. Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to candida, a luminal antigen. Pediatr. Allergy Immunol. 2010, 21:e747-e755.
28. Jyonouchi H., Geng L., Cushing-Ruby A., Quraishi H. Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J. Neuroinflammation 2008, 5:52.
29. Jyonouchi H., Geng L., Ruby A., Reddy C., Zimmerman-Bier B. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J. Pediatr. 2005, 146:605-610.
30. Jyonouchi H., Geng L., Ruby A., Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 2005, 51:77-85.
31. Jyonouchi H., G L., Ruby A., Reddy C. Suboptimal responses to dietary intervention in children with autism spectrum disorders and Non-IgE mediated food allergy. Autism Research Advances 2007, 169-184. Nova Science Publishers, Inc. L.B. Zhao (Ed.).
32. Kim S.H., Song J.Y., Joo E.J., Lee K.Y., Ahn Y.M., Kim Y.S. EGR3 as a potential susceptibility gene for schizophrenia in Korea. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:1355-1360.
33. Kimura A., Kishimoto T. Th17 cells in inflammation. Int. Immunopharmacol. 2011, 11:319-322.
34. Kyogoku C., Yanagi M., Nishimura K., Sugiyama D., Morinobu A., Fukutake M., Maeda K., Shirakawa O., Kuno T., Kumagai S. Association of calcineurin A gamma subunit (PPP3CC) and early growth response 3 (EGR3) gene polymorphisms with susceptibility to schizophrenia in a Japanese population. Psychiatry Res. 2011, 185:16-19.
35. Marchetto M.C., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., Chen G., Gage F.H., Muotri A.R. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
36. Nassef M., Shapiro G., Casale T.B. Identifying and managing rhinitis and its subtypes: allergic and nonallergic components-a consensus report and materials from the Respiratory and Allergic Disease Foundation. Curr. Med. Res. Opin. 2006, 22:2541-2548.
37. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
38. Parihar A., Eubank T.D., Doseff A.I. Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J. Innate Immun. 2010, 2:204-215.
39. Ransohoff R.M., Cardona A.E. The myeloid cells of the central nervous system parenchyma. Nature 2010, 468:253-262.
40. Rodriguez M., Alvarez-Erviti L., Blesa F.J., Rodriguez-Oroz M.C., Arina A., Melero I., Ramos L.I., Obeso J.A. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease. Neurobiol. Dis. 2007, 28:316-325.
41. Rudan I. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity. Psychiatr. Danub. 2010, 22:190-192.
42. Schendel D., Rice C., Cunniff C. The contribution of rare diseases to understanding the epidemiology of neurodevelopmental disabilities. Adv. Exp. Med. Biol. 2010, 686:433-453.
43. Serbina N.V., Jia T., Hohl T.M., Pamer E.G. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 2008, 26:421-452.
44. Singh V.K. Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism. Ann. Clin. Psychiatry 2009, 21:148-161.
45. Toro R., Konyukh M., Delorme R., Leblond C., Chaste P., Fauchereau F., Coleman M., Leboyer M., Gillberg C., Bourgeron T. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet. 2010, 26:363-372.
46. Urra X., Villamor N., Amaro S., Gomez-Choco M., Obach V., Oleaga L., Planas A.M., Chamorro A. Monocyte subtypes predict clinical course and prognosis in human stroke. J. Cereb. Blood Flow Metab. 2009, 29:994-1002.
47. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57:67-81.
48. Wang L.W., Berry-Kravis E., Hagerman R.J. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 2010, 7:264-274.
49. Yamamoto-Furusho J.K., Podolsky D.K. Innate immunity in inflammatory bowel disease. World J. Gastroenterol. 2007, 13:5577-5580.
50. Yuan T.M., Sun Y., Zhan C.Y., Yu H.M. Intrauterine infection/inflammation and perinatal brain damage: role of glial cells and Toll-like receptor signaling. J. Neuroimmunol. 2010, 229:16-25.